Bill Text: NY A01075 | 2011-2012 | General Assembly | Introduced
Bill Title: Establishes pedigree meaning an electronic record containing information regarding each distribution of a prescription drug, originating from a manufacturer, through acquisition by or transfer to one or more wholesalers, manufacturers, or pharmacies, until final sale or transfer to a pharmacy or other person furnishing, administering, or dispensing the prescription drug.
Spectrum: Moderate Partisan Bill (Democrat 18-4)
Status: (Introduced - Dead) 2012-01-04 - referred to higher education [A01075 Detail]
Download: New_York-2011-A01075-Introduced.html
S T A T E O F N E W Y O R K ________________________________________________________________________ 1075 2011-2012 Regular Sessions I N A S S E M B L Y (PREFILED) January 5, 2011 ___________ Introduced by M. of A. PAULIN, TITONE, GOTTFRIED, GALEF, CLARK -- Multi-Sponsored by -- M. of A. BOYLAND, BURLING, COLTON, COOK, DINOW- ITZ, HIKIND, HOOPER, LATIMER, J. MILLER, ORTIZ, RAIA, P. RIVERA, ROBINSON, SWEENEY, TOBACCO, WRIGHT -- read once and referred to the Committee on Higher Education AN ACT to amend the education law, in relation to pedigree for prescription drugs THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: 1 Section 1. Section 6802 of the education law is amended by adding a 2 new subdivision 23 to read as follows: 3 23. "PEDIGREE" MEANS AN ELECTRONIC RECORD CONTAINING INFORMATION 4 REGARDING EACH TRANSACTION, RESULTING IN A CHANGE OF OWNERSHIP, OF A 5 PRESCRIPTION DRUG, ORIGINATING FROM A MANUFACTURER, THROUGH ACQUISITION 6 BY OR TRANSFER TO ONE OR MORE WHOLESALERS, MANUFACTURERS, REPACKAGERS, 7 OR PHARMACIES, UNTIL FINAL SALE OR TRANSFER TO A PHARMACY OR OTHER 8 PERSON FURNISHING, ADMINISTERING, OR DISPENSING THE PRESCRIPTION DRUG, 9 AS PROVIDED IN SECTION SIXTY-EIGHT HUNDRED TEN-B OF THIS ARTICLE. 10 S 2. The education law is amended by adding a new section 6810-b to 11 read as follows: 12 S 6810-B. PEDIGREE. 1. A. EVERY MANUFACTURER SHALL ESTABLISH AND MAIN- 13 TAIN A PEDIGREE FOR EACH PRESCRIPTION DRUG, AND EVERY WHOLESALER, PHAR- 14 MACY OR OTHER PERSON FURNISHING OR DISPENSING A PRESCRIPTION DRUG SHALL 15 MAINTAIN A PEDIGREE FOR EACH PRESCRIPTION DRUG. 16 B. FOR PURPOSES OF THIS SECTION, "MANUFACTURER" MEANS A PERSON WHO 17 PREPARES, DERIVES, MANUFACTURES, PRODUCES OR REPACKAGES A PRESCRIPTION 18 DRUG. MANUFACTURER ALSO MEANS THE HOLDER OR HOLDERS OF A NEW DRUG APPLI- 19 CATION (NDA), AN ABBREVIATED NEW DRUG APPLICATION (ANDA), OR A BIOLOGICS 20 LICENSE APPLICATION (BLA), PROVIDED THAT SUCH APPLICATION HAS BEEN 21 APPROVED; A MANUFACTURER'S THIRD PARTY LOGISTICS PROVIDER; A PRIVATE EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD02278-02-1 A. 1075 2 1 LABEL DISTRIBUTOR (INCLUDING COLICENSED PARTNERS) FOR WHOM THE PRIVATE 2 LABEL DISTRIBUTOR'S PRESCRIPTION DRUGS ARE ORIGINALLY MANUFACTURED AND 3 LABELED FOR THE DISTRIBUTOR AND HAVE NOT BEEN REPACKAGED; OR THE 4 DISTRIBUTOR AGENT FOR THE MANUFACTURER, CONTRACT MANUFACTURER, OR 5 PRIVATE LABEL DISTRIBUTOR, WHETHER THE ESTABLISHMENT IS A MEMBER OF THE 6 MANUFACTURER'S AFFILIATED GROUP (REGARDLESS OF WHETHER THE MEMBER TAKES 7 TITLE TO THE DRUG) OR IS A CONTRACT DISTRIBUTOR SITE. 8 C. FOR PURPOSES OF THIS SECTION, "REPACKAGER" MEANS A PERSON OR ENTITY 9 THAT IS REGISTERED WITH THE FEDERAL FOOD AND DRUG ADMINISTRATION AS A 10 REPACKAGER AND OPERATES AN ESTABLISHMENT THAT PACKAGES FINISHED DRUGS 11 FROM BULK OR THAT REPACKAGES PRESCRIPTION DRUGS INTO DIFFERENT CONTAIN- 12 ERS, EXCLUDING SHIPPING CONTAINERS. 13 D. FOR PURPOSES OF THIS SECTION, "THIRD PARTY LOGISTICS PROVIDER" 14 MEANS AN ENTITY LICENSED AS A WHOLESALER THAT CONTRACTS WITH A MANUFAC- 15 TURER OF PRESCRIPTION DRUGS TO PROVIDE OR COORDINATE WAREHOUSING, 16 DISTRIBUTION OR OTHER SIMILAR SERVICES ON BEHALF OF A MANUFACTURER, BUT 17 FOR WHICH THERE IS NO CHANGE OF OWNERSHIP IN THE PRESCRIPTION DRUGS. 18 2. A PEDIGREE SHALL BE IN SUCH FORM AND CONTAIN SUCH INFORMATION AS 19 SHALL BE DETERMINED BY THE DEPARTMENT. EACH PEDIGREE SHALL MINIMALLY 20 INCLUDE FOR EACH DISTRIBUTION ALL OF THE FOLLOWING INFORMATION: 21 A. THE SOURCE OF THE PRESCRIPTION DRUG, INCLUDING THE NAME AND PRINCI- 22 PAL ADDRESS OF THE SELLER OR TRANSFEROR; 23 B. THE PROPRIETARY AND ESTABLISHED NAME OF THE PRESCRIPTION DRUG, THE 24 QUANTITY OF THE PRESCRIPTION DRUG, ITS DOSAGE FORM AND DOSAGE STRENGTH, 25 THE DATE OF THE PURCHASE OR TRANSFER, THE INVOICE NUMBER, CONTAINER 26 SIZE, EXPIRATION DATE, LOT NUMBER, NATIONAL DRUG CODE, AND, WHEN AVAIL- 27 ABLE, STANDARDIZED NUMERICAL IDENTIFIER, OF THE PRESCRIPTION DRUG; 28 C. THE BUSINESS NAME AND ADDRESS OF EACH OWNER OF THE PRESCRIPTION 29 DRUG AND ITS SHIPPING INFORMATION, INCLUDING THE NAME AND ADDRESS OF THE 30 FACILITY OF EACH PERSON CERTIFYING DELIVERY OR RECEIPT OF THE 31 PRESCRIPTION DRUG; AND 32 D. A CERTIFICATION UNDER PENALTY OF PERJURY FROM THE DESIGNATED REPRE- 33 SENTATIVE OF THE MANUFACTURER, WHOLESALER OR PHARMACY THAT THE INFORMA- 34 TION CONTAINED THEREIN IS TRUE AND ACCURATE. 35 3. A SINGLE PEDIGREE SHALL INCLUDE EVERY CHANGE OF OWNERSHIP OF A 36 PRESCRIPTION DRUG FROM ITS INITIAL MANUFACTURE THROUGH TO ITS FINAL 37 TRANSACTION TO A PHARMACY OR OTHER PERSON FOR FURNISHING, ADMINISTERING, 38 OR DISPENSING THE PRESCRIPTION DRUG, REGARDLESS OF REPACKAGING OR 39 ASSIGNMENT OF ANOTHER NATIONAL DRUG CODE DIRECTORY NUMBER. PRESCRIPTION 40 DRUGS THAT ARE REPACKAGED SHALL BE SERIALIZED BY THE REPACKAGER AND A 41 PEDIGREE SHALL BE PROVIDED THAT REFERENCES THE PEDIGREE OF THE ORIGINAL 42 PACKAGE OR PACKAGES PROVIDED BY THE MANUFACTURER. 43 4. A PEDIGREE SHALL TRACK EACH PRESCRIPTION DRUG AT THE SMALLEST PACK- 44 AGE OR IMMEDIATE CONTAINER DISTRIBUTED BY THE MANUFACTURER, RECEIVED AND 45 DISTRIBUTED BY THE WHOLESALER OR REPACKAGER, AND RECEIVED BY THE PHARMA- 46 CY OR ANOTHER PERSON FURNISHING, ADMINISTERING, OR DISPENSING THE 47 PRESCRIPTION DRUG. FOR PURPOSES OF THIS SECTION, "SMALLEST PACKAGE OR 48 IMMEDIATE CONTAINER" OF A PRESCRIPTION DRUG SHALL INCLUDE ANY 49 PRESCRIPTION DRUG PACKAGE OR CONTAINER MADE AVAILABLE TO A REPACKAGER, 50 WHOLESALER, PHARMACY, OR OTHER ENTITY FOR REPACKAGING OR REDISTRIBUTION, 51 AS WELL AS THE SMALLEST UNIT MADE BY THE MANUFACTURER FOR SALE TO THE 52 PHARMACY OR OTHER PERSON FURNISHING, ADMINISTERING, OR DISPENSING THE 53 DRUG. 54 5. ANY RETURN OF A PRESCRIPTION DRUG TO A WHOLESALER OR MANUFACTURER 55 SHALL BE DOCUMENTED ON THE SAME PEDIGREE AS THE TRANSACTION THAT A. 1075 3 1 RESULTED IN THE RECEIPT OF THE PRESCRIPTION DRUG BY THE PARTY RETURNING 2 IT. 3 6. THE FOLLOWING TRANSACTIONS ARE EXEMPT FROM THE PEDIGREE REQUIRE- 4 MENTS CREATED BY THIS SECTION: 5 A. AN INTRACOMPANY SALE OR TRANSFER OF A PRESCRIPTION DRUG. FOR 6 PURPOSES OF THIS SECTION, "INTRACOMPANY SALE OR TRANSFER" MEANS ANY 7 TRANSACTION FOR ANY VALID BUSINESS PURPOSE BETWEEN A DIVISION, SUBSID- 8 IARY, PARENT, OR AFFILIATED OR RELATED COMPANY UNDER THE COMMON OWNER- 9 SHIP AND CONTROL OF THE SAME CORPORATE OR LEGAL ENTITY. 10 B. PRESCRIPTION DRUGS RECEIVED BY THE STATE OR A LOCAL GOVERNMENT 11 ENTITY FROM A DEPARTMENT OR AGENCY OF THE FEDERAL GOVERNMENT OR AN AGENT 12 OF THE FEDERAL GOVERNMENT SPECIFICALLY AUTHORIZED TO DELIVER 13 PRESCRIPTION DRUGS TO THE STATE OR LOCAL GOVERNMENT ENTITY. 14 C. THE PROVISION OF SAMPLES OF PRESCRIPTION DRUGS BY A MANUFACTURER'S 15 EMPLOYEE TO AN AUTHORIZED PRESCRIBER, PROVIDED THE SAMPLES ARE DISPENSED 16 WITHOUT CHARGE ONLY TO A PATIENT OF THE PRESCRIBER. 17 D. (I) A SALE, TRADE, OR TRANSFER OF A RADIOACTIVE DRUG BETWEEN ANY 18 TWO ENTITIES LICENSED BY THE DEPARTMENT OF HEALTH OR THE FEDERAL NUCLEAR 19 REGULATORY COMMISSION. 20 (II) THE EXEMPTION IN THIS PARAGRAPH SHALL REMAIN IN EFFECT UNLESS THE 21 DEPARTMENT DETERMINES THAT THE RISK OF COUNTERFEITING OR DIVERSION OF A 22 RADIOACTIVE DRUG IS SUFFICIENT TO REQUIRE A PEDIGREE, IN WHICH EVENT THE 23 EXEMPTION IN THIS PARAGRAPH SHALL BECOME INOPERATIVE AS PROVIDED IN A 24 REGULATION PROMULGATED BY THE DEPARTMENT. 25 E. THE SALE, TRADE, OR TRANSFER OF A DANGEROUS DRUG THAT IS LABELED BY 26 THE MANUFACTURER AS "FOR VETERINARY USE ONLY". 27 F. THE SALE, TRADE, OR TRANSFER OF COMPRESSED MEDICAL GAS. FOR 28 PURPOSES OF THIS SECTION, "COMPRESSED MEDICAL GAS" MEANS ANY SUBSTANCE 29 IN ITS GASEOUS OR CRYOGENIC LIQUID FORM THAT MEETS MEDICAL PURITY STAND- 30 ARDS AND HAS APPLICATION IN A MEDICAL OR HOMECARE ENVIRONMENT, INCLUD- 31 ING, BUT NOT LIMITED TO, OXYGEN AND NITROUS OXIDE. 32 G. THE SALE, TRADE, OR TRANSFER OF SOLUTIONS. FOR PURPOSES OF THIS 33 SECTION, "SOLUTIONS" MEANS ANY OF THE FOLLOWING: 34 (I) THOSE INTRAVENOUS PRODUCTS THAT, BY THEIR FORMULATION, ARE 35 INTENDED FOR THE REPLENISHMENT OF FLUIDS AND ELECTROLYTES, SUCH AS SODI- 36 UM, CHLORIDE, AND POTASSIUM AND CALORIES, SUCH AS DEXTROSE AND AMINO 37 ACIDS, OR BOTH. 38 (II) THOSE INTRAVENOUS PRODUCTS USED TO MAINTAIN THE EQUILIBRIUM OF 39 WATER AND MINERALS IN THE BODY, SUCH AS DIALYSIS SOLUTIONS. 40 (III) PRODUCTS THAT ARE INTENDED FOR IRRIGATION OR RECONSTITUTION, AS 41 WELL AS STERILE WATER, WHETHER INTENDED FOR THOSE PURPOSES OR FOR 42 INJECTION. 43 H. PRESCRIPTION DRUGS THAT ARE PLACED IN A SEALED PACKAGE WITH A 44 MEDICAL DEVICE OR MEDICAL SUPPLIES AT THE POINT OF FIRST SHIPMENT INTO 45 COMMERCE BY THE MANUFACTURER AND THE PACKAGE REMAINS SEALED UNTIL THE 46 DRUG AND DEVICE ARE USED, PROVIDED THAT THE PACKAGE IS ONLY USED FOR 47 SURGICAL PURPOSES. 48 I. A PRODUCT THAT MEETS EITHER OF THE FOLLOWING CRITERIA: 49 (I) A PRODUCT COMPRISED OF TWO OR MORE REGULATED COMPONENTS, SUCH AS A 50 DRUG/DEVICE, BIOLOGIC/DEVICE, OR DRUG/DEVICE/BIOLOGIC, THAT ARE PHYS- 51 ICALLY, CHEMICALLY, OR OTHERWISE COMBINED OR MIXED AND PRODUCED AS A 52 SINGLE ENTITY. 53 (II) TWO OR MORE SEPARATE PRODUCTS PACKAGED TOGETHER IN A SINGLE PACK- 54 AGE OR AS A UNIT AND COMPRISED OF DRUG AND DEVICE PRODUCTS OR DEVICE AND 55 BIOLOGICAL PRODUCTS. A. 1075 4 1 7. IF A MANUFACTURER, WHOLESALER, OR PHARMACY HAS REASONABLE CAUSE TO 2 BELIEVE THAT A PRESCRIPTION DRUG IN, OR HAVING BEEN IN, ITS POSSESSION 3 IS COUNTERFEIT OR THE SUBJECT OF A FRAUDULENT TRANSACTION, THE MANUFAC- 4 TURER, WHOLESALER, OR PHARMACY SHALL NOTIFY THE DEPARTMENT WITHIN SEVEN- 5 TY-TWO HOURS OF OBTAINING SUCH KNOWLEDGE. THIS SUBDIVISION SHALL APPLY 6 TO ANY PRESCRIPTION DRUG THAT HAS BEEN SOLD OR DISTRIBUTED IN OR THROUGH 7 THIS STATE. 8 8. EVERY PEDIGREE SHALL BE MAINTAINED FOR A PERIOD OF THREE YEARS OR A 9 REASONABLE PERIOD OF TIME AS DETERMINED BY THE COMMISSIONER, AND SHALL 10 BE MADE AVAILABLE FOR INSPECTION, UPON REASONABLE NOTICE, BY THE DEPART- 11 MENT. 12 9. A. A PEDIGREE SHALL BE MAINTAINED IN AN ELECTRONIC PEDIGREE TRACK- 13 ING OR ALTERNATIVE SYSTEM DETERMINED BY THE DEPARTMENT TO BE FEASIBLE. 14 IN DETERMINING WHETHER AN ELECTRONIC PEDIGREE TRACKING OR ALTERNATIVE 15 SYSTEM IS FEASIBLE, THE DEPARTMENT SHALL CONSIDER WHETHER SUCH SYSTEM OR 16 FORMAT IS: 17 (I) READILY AVAILABLE WITH RESPECT TO ALL PRESCRIPTION DRUGS, 18 (II) IN A STANDARDIZED NON-PROPRIETARY DATA FORMAT AND ARCHITECTURE, 19 AND WIDELY AVAILABLE TO MANUFACTURERS, WHOLESALERS AND PHARMACIES SO 20 THAT THE SYSTEM OR FORMAT IS CAPABLE OF BEING USED BY MANUFACTURERS, 21 WHOLESALERS AND PHARMACIES FROM SALE BY THE MANUFACTURER THROUGH ACQUI- 22 SITION BY OR TRANSFER TO A WHOLESALER, MANUFACTURER OR PHARMACY UNTIL 23 FINAL SALE OR TRANSFER TO A PHARMACY OR OTHER PERSON FURNISHING, ADMIN- 24 ISTERING OR DISPENSING THE PRESCRIPTION DRUG, AND 25 (III) CONSISTENT AND COMPATIBLE WITH FEDERAL REQUIREMENTS FOR AN ELEC- 26 TRONIC PEDIGREE TRACKING OR ALTERNATIVE SYSTEM AND A STANDARDIZED NUMER- 27 ICAL IDENTIFIER. 28 B. THE PROVISIONS OF THIS SECTION SHALL BECOME OPERATIVE ON JANUARY 29 FIRST, TWO THOUSAND SIXTEEN, WHICH SHALL BE THE PEDIGREE EFFECTIVE DATE; 30 PROVIDED, HOWEVER, IF AN ELECTRONIC PEDIGREE TRACKING OR ALTERNATIVE 31 SYSTEM IS NOT FEASIBLE BY THE PEDIGREE EFFECTIVE DATE, THE DEPARTMENT 32 SHALL ISSUE ONE-YEAR EXTENSIONS OF THE PEDIGREE EFFECTIVE DATE UNTIL THE 33 DEPARTMENT DETERMINES SUCH SYSTEM TO BE FEASIBLE. 34 10. A. COMMENCING ON JULY FIRST, TWO THOUSAND SIXTEEN, A WHOLESALER OR 35 OTHER PERSON FURNISHING A PRESCRIPTION DRUG SHALL NOT (I) SELL, TRANS- 36 FER, DISTRIBUTE, OR DELIVER A PRESCRIPTION DRUG WITHOUT PROVIDING A 37 PEDIGREE, OR (II) ACQUIRE A PRESCRIPTION DRUG WITHOUT RECEIVING A PEDI- 38 GREE. IF AN ELECTRONIC PEDIGREE TRACKING OR ALTERNATIVE SYSTEM IS NOT 39 FEASIBLE BY THE PEDIGREE EFFECTIVE DATE, THE DEPARTMENT MAY EXTEND THE 40 DATE UPON WHICH THE PROVISIONS OF THIS PARAGRAPH SHALL BECOME OPERATIVE 41 AS IT SHALL DETERMINE IN ITS DISCRETION. 42 B. COMMENCING ON JULY FIRST, TWO THOUSAND SEVENTEEN, A PHARMACY OR 43 OTHER PERSON FURNISHING OR DISPENSING A PRESCRIPTION DRUG SHALL NOT (I) 44 SELL, TRANSFER, DISTRIBUTE, OR DELIVER A PRESCRIPTION DRUG WITHOUT 45 PROVIDING A PEDIGREE, OR (II) ACQUIRE A PRESCRIPTION DRUG WITHOUT 46 RECEIVING A PEDIGREE. IF AN ELECTRONIC PEDIGREE TRACKING OR ALTERNATIVE 47 SYSTEM IS NOT FEASIBLE BY THE PEDIGREE EFFECTIVE DATE, THE DEPARTMENT 48 MAY EXTEND THE DATE UPON WHICH THE PROVISIONS OF THIS PARAGRAPH SHALL 49 BECOME OPERATIVE AS IT SHALL DETERMINE IN ITS DISCRETION. 50 11. A. (I) UPON THE EFFECTIVE DATE OF FEDERAL LEGISLATION OR ADOPTION 51 OF A FEDERAL REGULATION GOVERNING THE FORM OR CONTENT OF PEDIGREE OR THE 52 STANDARDS AND TECHNOLOGIES FOR THE IDENTIFICATION, VALIDATION, TRACKING 53 AND TRACING AND AUTHENTICATION FOR PRESCRIPTION DRUGS, THE PROVISIONS OF 54 THIS SECTION THAT ARE INCONSISTENT WITH SUCH FEDERAL LEGISLATION OR 55 FEDERAL REGULATION SHALL BECOME INOPERATIVE. A. 1075 5 1 (II) WITHIN NINETY DAYS OF THE ENACTMENT OF FEDERAL LEGISLATION OR 2 ADOPTION OF A FEDERAL REGULATION THAT IS INCONSISTENT WITH THE 3 PROVISIONS OF THIS SECTION AS PROVIDED IN SUBPARAGRAPH (I) OF THIS PARA- 4 GRAPH, THE DEPARTMENT SHALL PUBLISH A NOTICE STATING WHICH PROVISIONS OF 5 THIS SECTION ARE INOPERATIVE. THE DEPARTMENT SHALL HAVE THE AUTHORITY TO 6 ADOPT EMERGENCY REGULATIONS AS IT DEEMS NECESSARY IN ITS DETERMINATION 7 TO REFLECT THE INOPERATION OF ANY PROVISION OF THIS SECTION AS PROVIDED 8 IN THIS PARAGRAPH. 9 B. (I) IF THE FEDERAL FOOD AND DRUG ADMINISTRATION ENACTS ANY RULE OR 10 STANDARD OR TAKES ANY OTHER ACTION THAT IS INCONSISTENT WITH ANY 11 PROVISION OF THIS SECTION GOVERNING THE FORM OR CONTENT OF PEDIGREE OR 12 THE STANDARDS AND TECHNOLOGIES FOR THE IDENTIFICATION, VALIDATION, 13 TRACKING AND TRACING, AND AUTHENTICATION FOR PRESCRIPTION DRUGS, SUCH 14 PROVISION OF THIS SECTION SHALL BE DEEMED INOPERATIVE. 15 (II) WITHIN NINETY DAYS OF THE FEDERAL FOOD AND DRUG ADMINISTRATION 16 ENACTING ANY RULE OR STANDARD OR TAKING ANY OTHER ACTION THAT IS INCON- 17 SISTENT WITH THE PROVISIONS OF THIS SECTION AS PROVIDED IN SUBPARAGRAPH 18 (I) OF THIS PARAGRAPH, THE DEPARTMENT SHALL PUBLISH A NOTICE STATING 19 WHICH PROVISIONS OF THIS SECTION ARE INOPERATIVE. THE DEPARTMENT SHALL 20 HAVE THE AUTHORITY TO ADOPT EMERGENCY REGULATIONS AS IT DEEMS NECESSARY 21 IN ITS DETERMINATION TO REFLECT THE INOPERATION OF ANY PROVISION OF THIS 22 SECTION AS PROVIDED IN THIS PARAGRAPH. 23 12. A. ALL UNITS OF PRESCRIPTION DRUGS IN THE POSSESSION OF A WHOLE- 24 SALER OR PHARMACY FOR WHICH THE MANUFACTURER DOES NOT HOLD LEGAL TITLE 25 ON THE PEDIGREE EFFECTIVE DATE SHALL NOT BE SUBJECT TO THE PEDIGREE 26 REQUIREMENTS SET FORTH IN THIS SECTION; PROVIDED, HOWEVER, IF ANY SUCH 27 UNITS OF PRESCRIPTION DRUGS ARE SUBSEQUENTLY RETURNED TO THE MANUFACTUR- 28 ER, THEY SHALL BE SUBJECT TO THE PEDIGREE REQUIREMENTS IF THE MANUFAC- 29 TURER DISTRIBUTES SUCH UNITS IN THIS STATE. 30 B. ALL UNITS OF PRESCRIPTION DRUGS IN THE POSSESSION OF A MANUFACTURER 31 FOR WHICH THE MANUFACTURER DOES NOT HOLD LEGAL TITLE ON THE PEDIGREE 32 EFFECTIVE DATE SHALL NOT BE SUBJECT TO THE PEDIGREE REQUIREMENTS SET 33 FORTH IN THIS SECTION. 34 13. ANY PERSON WHO VIOLATES ANY PROVISION OF THIS SECTION SHALL BE 35 SUBJECT TO A FINE OF NOT MORE THAN TWO THOUSAND DOLLARS PER VIOLATION. 36 IN ADDITION, ANY PRESCRIPTION DRUG DISTRIBUTED, TRANSFERRED, ADMINIS- 37 TERED, FURNISHED, OR DISPENSED IN VIOLATION OF THIS SECTION SHALL BE 38 CONTRABAND AND SUBJECT TO SEIZURE EITHER BY THE DEPARTMENT, THE STATE 39 BOARD OF PHARMACY OR ANY LAW ENFORCEMENT OFFICER OF THE STATE. 40 S 3. This act shall take effect on the one hundred eightieth day after 41 it shall have become a law. The department of education shall promulgate 42 rules and regulations, issue forms and take any other action necessary 43 to implement the provisions of this act on or before the pedigree effec- 44 tive date, as provided in paragraph b of subdivision 9 of section 6810-b 45 of the education law, as added by section two of this act.